Veracyte and Genzyme, a Sanofi (SNY -0.6%) company, says recently published data suggests that...

|About: Sanofi (SNY)|By:, SA News Editor

Veracyte and Genzyme, a Sanofi (SNY -0.6%) company, says recently published data suggests that routine clinical use of Veracyte's gene expression classifier Afirma helps significantly reduce certain thyroid cancer surgeries.